Next Article in Journal
eHealth and mHealth in Chronic Diseases—Identification of Barriers, Existing Solutions, and Promoters Based on a Survey of EU Stakeholders Involved in Regions4PerMed (H2020)
Previous Article in Journal
Vitamin D and Histological Features of Breast Cancer: Preliminary Data from an Observational Retrospective Italian Study
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JPM
Volume 12
Issue 3
10.3390/jpm12030466
jpm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to J. Pers. Med. 2021, 11(7), 655.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Kao et al. RNF8–CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer. J. Pers. Med. 2021, 11, 655

by
Chieh-Ni Kao
1,2,
Sin-Hua Moi
3,
Ming-Feng Hou
2,*,
Chi-Wen Luo
2,
Fang-Ming Chen
2 and
Mei-Ren Pan
1,4,*
1
Graduate Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan
2
Division of Breast Oncology and Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan
3
Center of Cancer Program Development, E-Da Cancer Hospital, I-Shou University, Kaohsiung 824, Taiwan
4
Drug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung 807, Taiwan
*
Authors to whom correspondence should be addressed.
J. Pers. Med. 2022, 12(3), 466; https://doi.org/10.3390/jpm12030466
Submission received: 23 February 2022 / Accepted: 7 March 2022 / Published: 15 March 2022
Versions Notes
The authors would like to make corrections to a recently published paper [1]. The reason for the correction is that Figure 5 was misplaced with all TNBC data, not TNBC LN (+) data. In addition, typo errors and citation errors were shown in Sections 3.1 and 3.2, and Reference No. 6.
Original Figure 5:
  • Jpm 12 00466 i001
We would like it to be corrected as shown below.
1.
New Figure 5:
  • Jpm 12 00466 i002
2.
The result of Section 3.1. Clinicopathological Characteristics and Progression of Breast Cancer.
A total of 264 LN+ patients, with a median age of 56 years.
3.
The result of Section 3.2. A Significant Correlation Among RNF8, SNAI1, and CDH1 mRNA Expression in Patients with Breast Cancer.
SNAI1 showed a significant positive correlation (r value = 0.185).
4.
The right reference No. 6 is: Kalluri, R.; Weinberg, R.A. The basics of epithelial-mesenchymal transition. J. Clin. Investig. 2009, 119, 1420–1428. http://doi.org/10.1172/jci39104.
These changes do not change the results or conclusions of our paper. The authors would like to apologize to readers of JPM for this error. The published version will be updated on the article webpage, with a reference to this correction notice.

Reference

  1. Kao, C.-N.; Moi, S.-H.; Hou, M.-F.; Luo, C.-W.; Chen, F.-M.; Pan, M.-R. RNF8–CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer. J. Pers. Med. 2021, 11, 655. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Kao, C.-N.; Moi, S.-H.; Hou, M.-F.; Luo, C.-W.; Chen, F.-M.; Pan, M.-R. Correction: Kao et al. RNF8–CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer. J. Pers. Med. 2021, 11, 655. J. Pers. Med. 2022, 12, 466. https://doi.org/10.3390/jpm12030466

AMA Style

Kao C-N, Moi S-H, Hou M-F, Luo C-W, Chen F-M, Pan M-R. Correction: Kao et al. RNF8–CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer. J. Pers. Med. 2021, 11, 655. Journal of Personalized Medicine. 2022; 12(3):466. https://doi.org/10.3390/jpm12030466

Chicago/Turabian Style

Kao, Chieh-Ni, Sin-Hua Moi, Ming-Feng Hou, Chi-Wen Luo, Fang-Ming Chen, and Mei-Ren Pan. 2022. "Correction: Kao et al. RNF8–CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer. J. Pers. Med. 2021, 11, 655" Journal of Personalized Medicine 12, no. 3: 466. https://doi.org/10.3390/jpm12030466

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop